Costs and management of patients with hemophilia A in France: the Hemraude study.

Laurendeau, C; Goudemand, J; Trossaert, M; Polack, B; Varin, R; Godard, C; Hadim, F; Detournay, B

Laurendeau, C; Goudemand, J; Trossaert, M; Polack, B; Varin, R; Godard, C; Hadim, F; Detournay, B.

Afiliação

Laurendeau C; Cemka, 43, Boulevard Maréchal Joffre, 92340, Bourg-la-Reine, France.
Goudemand J; Department of Hemostasis and Transfusion, Lille University Hospital, Lille, France.
Trossaert M; Hematology Department, University Hospital, Nantes, France.
Polack B; Laboratory TIMC-IMAG, UMRS 5525, Hematology Department, University Hospital, CNRS University Grenoble-Alpes, Grenoble, France.
Varin R; Clinical Pharmacy Department, University Hospital, Rouen, France.
Godard C; Roche, Boulogne, France.
Hadim F; Roche, Boulogne, France.
Detournay B; Cemka, 43, Boulevard Maréchal Joffre, 92340, Bourg-la-Reine, France. bruno.detournay@cemka.fr.

Eur J Health Econ ; 23(1): 23-32, 2022 Feb.

Article em En | MEDLINE | ID: mdl-34236542

Assuntos

Infecções por HIV; Hemofilia A; Idoso; Fator VIII/uso terapêutico; Hemofilia A/tratamento farmacológico; Hemorragia; Humanos; Masculino; Estudos Retrospectivos

Palavras-chave

Bypassing agent; Direct costs; Economic burden; Factor VIII; Hemophilia A; Inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Hemofilia A Tipo de estudo: Guideline / Health_economic_evaluation / Observational_studies Limite: Aged / Humans / Male Idioma: En Revista: Eur J Health Econ Assunto da revista: SAUDE PUBLICA / SERVICOS DE SAUDE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google